Results overview: Found 3 records in 0.01 seconds.
Articles, 3 records found
Articles 3 records found  
1.
12 p, 1.5 MB External validity of docetaxel triplet trials in advanced gastric cancer : are there patients who still benefit? / Jimenez-Fonseca, Paula (Hospital Universitario Central de Asturias. ISPA) ; Carmona-Bayonas, Alberto (Fundación Séneca (04515/GERM/06)) ; Martínez de Castro, Eva (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Custodio, Ana (Hospital Universitario La Paz (Madrid)) ; Pericay, Carles (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Hernandez-San Gil, Raquel (Hospital Universitario de Canarias (La Laguna)) ; Aguado, Gema (Hospital General Universitario Gregorio Marañón) ; Castro Unanua, Natalia (Complejo Hospitalario de Navarra) ; Cano, Juana María (Hospital General Universitario de Ciudad Real) ; López López, Flora (Hospital Universitario 12 de Octubre (Madrid)) ; Garrido Salvo, Marcelo (Pontificia Universidad Católica de Chile) ; Fernández Montes, Ana (Complejo Hospitalario de Orense) ; Visa, Laura (Hospital Universitario El Mar) ; Sánchez Cánovas, Manuel (Hospital General Universitario Morales Meseguer (Múrcia)) ; Limón, María Luisa (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Martínez Lago, Nieves (Complejo Hospitalario Universitario de A Coruña) ; Pimentel, Paola (Hospital Santa Lucía) ; Hurtado-Nuño, Alicia (Hospital Universitario Fundación Alcorcón) ; Azkárate, Aitor (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Longo, Federico (Hospital Universitario Ramón y Cajal (Madrid)) ; Díez García, Marc (Hospital Universitari Vall d'Hebron) ; Arias-Martinez, Aránzazu. (Hospital Universitario Central de Asturias) ; Saurí Nadal, Tamara (Hospital Clínic i Provincial de Barcelona) ; Martín Carnicero, Alfonso (Hospital San Pedro de Alcántara) ; Mangas, Montserrat (Hospital de Galdakao (Usansolo, Biscaia)) ; Martín-Richard, Marta (Institut d'Investigació Biomèdica Sant Pau) ; Granja Ortega, Mónica (Hospital Universitario Clínico San Carlos (Madrid)) ; Ramchandani, Avinash (Hospital Universitario Insular de Gran Canaria) ; Hernández Pérez, Carolina (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; Cerdà, Paula (Centro Médico Tecknon) ; Gil-Negrete Laborda, Aitziber (Hospital de Donostia (Sant Sebastià, País Basc)) ; Calvo, Mariona (Institut Català d'Oncologia) ; Vidal Tocino, Rosario (Complejo Asistencial Universitario de Salamanca. IBSAL) ; Gallego Plazas, Javier (Hospital General Universitario de Elche)
Background: The purpose of our study was to develop an online calculator to estimate the effect of docetaxel triplets (DPF) in first line of advanced gastric cancer (AGC), and to assess the external validity of docetaxel trials in individual patients. [...]
2021 - 10.1007/s10120-020-01116-x
Gastric Cancer, Vol. 24 Núm. 2 (march 2021) , p. 445-456  
2.
12 p, 523.4 KB Chemorefractory Gastric Cancer : The Evolving Terrain of Third-Line Therapy and Beyond / Alsina, Maria (Vall d'Hebron Institut d'Oncologia) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Díez García, Marc (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
Gastric and gastro-oesophageal junction cancers (GC) are the fourth cause of cancer-related deaths, representing an international problem which needs a proper assessment. Beyond being an aggressive disease, which rapidly progress to different lines of treatment, patients suffering GC normally present a non-depreciable number of symptoms that make them especially fragile. [...]
2022 - 10.3390/cancers14061408
Cancers, Vol. 14 (march 2022)  
3.
6 p, 483.6 KB How I treat gastric adenocarcinoma / Alsina, Maria (Universitat Autònoma de Barcelona. Facultat de Medicina) ; Miquel, Josep Maria (Vall d'Hebron Institut d'Oncologia) ; Díez García, Marc (Vall d'Hebron Institut d'Oncologia) ; Castro, Sandra (Hospital Universitari Vall d'Hebron) ; Tabernero, Josep (Universitat Autònoma de Barcelona. Facultat de Medicina)
Gastric and gastro-oesophageal junction cancer (GC) represents a worldwide problem, this being the fifth most common malignancy. The fragility of patients with GC together with the aggressiveness of this tumour makes it as one of the most difficult neoplasias to manage. [...]
2019 - 10.1136/esmoopen-2019-000521
ESMO open, Vol. 4 (july 2019)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.